News

Now Hiring: Biomarker Scientist (Onsite, Mountain View)

Now Hiring: Protein Scientist (Onsite, Mountain View)

Now Hiring: Bioinformatics Scientist (Onsite, Mountain View)

Now Hiring: Research Associate or Sr. RA (Onsite, Mountain View)

Asieris Appoints Dr. Badrinath Konety to Scientific Advisory Board

Asieris’ Multinational Phase III Clinical Trial for the Non-Surgical Treatment of HSIL Has Completed Enrollment

The First Domestic Case in Boao, Ushering in a New Option for Diagnosing Bladder Cancer

Asieris to publish the study protocol of Cevira® as a novel treatment in patients with high grade squamous intraepithelial lesion (HSIL) on BMJ Open

2022 ASCO, Asieris Presented a Study Protocol of Muscle Invasive Bladder Cancer(MIBC)

Asieris to present a study protocol of APL-1202 in combination with BeiGene’s tislelizumab as neoadjuvant therapy (NAC) for muscle invasive bladder cancer (MIBC) patients at 2022 ASCO annual meeting